Whitehawk Therapeutics (WHWK) Notes Payables (2010 - 2020)

Whitehawk Therapeutics (WHWK) reported Notes Payables of $9.0 million for Q4 2020, down 27.11% quarter-over-quarter from $12.4 million in Q4 2016.

Whitehawk Therapeutics (WHWK) Notes Payables (2010 - 2020) Analysis & Trends

Whitehawk Therapeutics (WHWK) has 8 years of Notes Payables data on file, last reported at $9.0 million in Q4 2020.

Notes Payables for Q4 2020 came in at $9.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $9.0 million (changed N/A YoY), and the FY2020 annual result was $9.0 million, changed N/A from the prior year.
Notes Payables eased to $9.0 million in Q4 2020 per WHWK's latest filing, from $12.4 million in the prior quarter.
Over five years, Notes Payables peaked at $12.4 million in Q4 2016 and troughed at $160000.0 in Q1 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Whitehawk Therapeutics	310.18 Mn	187.14 Mn	-

Download Data